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Background: T follicular helper (Tfh) cells are essential for B cell responses against viruses and require B cell lymphoma 6
(BCL6).
Results: Early growth response gene 2 (EGR2) and EGR3 intrinsically regulate Bcl6 and Tfh cells.
Conclusion: EGR2 and -3 are novel regulators of BCL6-mediated Tfh development.
Significance: In addition to controlling inflammation, EGR2 and -3 regulate Tfh function during antiviral immunoresponses.
T follicular helper (Tfh) cells support differentiation of B cells
to plasma cells and high affinity antibody production in germi-
nal centers (GCs), and Tfh differentiation requires the function
of B cell lymphoma6 (BCL6).Wehave nowdiscovered that early
growth response gene 2 (EGR2) and EGR3 directly regulate the
expression of Bcl6 in Tfh cells, which is required for their func-
tion in regulation of GC formation. In the absence of EGR2 and
-3, the expression of BCL6 in Tfh cells is defective, leading to
impaired differentiation of Tfh cells, resulting in a failure to
formGCs following virus infection and defects in production of
antiviral antibodies. Enforced expression of BCL6 in EGR2/3-
deficient CD4 T cells partially restored Tfh differentiation and
GC formation in response to virus infection. Our findings dem-
onstrate a novel function of EGR2/3 that is important for Tfh
cell development and Tfh cell-mediated B cell immune
responses.
Humoral immunity depends on help provided by T follicular
helper (Tfh)4 cells, which support the differentiation of
antigen-specific B cells intomemory and plasma cells in germi-
nal centers (GCs) (1, 2). Recently, it has been proposed that Tfh
differentiation consists of two stages, the induction of CXCR5
expression in the T cell zone and the expression of BCL6, a
transcription factor that is essential for Tfh differentiation (2),
aftermigration into the interfollicular and follicular regions (3).
BCL6 has been discovered to be a master regulator of Tfh dif-
ferentiation (4–6). BCL6 is expressed in both Tfh and GC B
cells and is autonomously required for the function of both cells
(7–11). Although it is necessary for Tfh cell development, the
mechanism of BCL6 function in Tfh differentiation is still
poorly understood. BLIMP1 is a negative regulator of Tfh dif-
ferentiation through transcriptional repression of theBcl6 gene
(4). In addition to BCL6, the transcription factors c-MAF,
BATF, and IRF4 have been found to regulate Tfh cell differen-
tiation (12–15) by regulating either Bcl6 expression (13) or
STAT3-mediated IL-21 expression (15, 16). Moreover,
SH2D1A and ICOS are required for Tfh cell migration into the
GC area and are essential for GC formation (12, 17).
Early growth response gene 2 (EGR2) and EGR3,members of
the EGR transcription factor family, are important for the con-
trol of inflammatory autoimmunity and antigen receptor-me-
diated lymphocyte proliferation (18, 19). Although EGR2 and
-3 are expressed in effector phenotype T cells, their roles in
regulation of T cell effector function are still not fully under-
stood. Analysis of the global gene expression patterns of EGR2/
3-deficient T cells revealed that in addition to inflammatory
cytokines (19), the expression of the Tfh regulator Bcl6 was sig-
nificantly reduced, whereas Prdm1 (BLIMP1), a functional antag-
onist of BCL6 and Tfh differentiation, was increased. We found
that the differentiation of Tfh cells in CD2-Egr2/Egr3/
mice, which lack EGR2 and -3 in B andT cells (19), was severely
defective, resulting in failure to form GCs after virus infection.
EGR2 directly controlled the expression of Bcl6 in Tfh cells,
whereas enforced expression of BCL6 in EGR2/3-deficientCD4
T cells effectively restored GC formation. Thus, we have dis-
covered a novel function of EGR2/3 in regulation of Bcl6
expression, Tfh differentiation, and GC development.
Experimental Procedures
Mice—Egr3/ and CD2-specific Egr2/ (K2/3) mice on
theC57BL/6 backgroundwere described in our previous report
(19). C57BL/6 mice were used as controls in all experiments.
Rag2/ mice on a C57BL/6J background were bred in-house
and described in our previous report (19). All mice were main-
tained in the Biological Services Unit, Brunel University, and
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used according to established institutional guidelines under the
authority of a UK Home Office project license.
Antibodies and Flow Cytometry—Fluorescein isothiocyanate
(FITC)-conjugated antibodies to B220, PD1, GL7, and CD4;
eFluor 450-labeled antibody toCD4; phycoerythrin-conjugated
antibodies to CD4, CD19, CD25, PD1, CD62L, CD69, IgM,
EGR2, and BCL6; PerCP-labeled antibody to CXCR5 and B220;
phycoerythrin-Cy7-labeled antibody to B220; biotin-conju-
gated antibody to CXCR5; allophycocyanin-conjugated anti-
bodies to CD44 and EGR2, and allophycocyanin-labeled
streptavidin were obtained from eBioscience. For flow cytom-
etry analysis, single cell suspensionswere analyzed on aCanto II
system (BD Immunocytometry Systems), and the data were
analyzed using FlowJo (Tree Star). Cell sorting was performed
on a FACSAria sorter with DIVA option (BD Immunocytom-
etry Systems).
Cell Isolation and Stimulation—Naive CD4 T and B cells
were purified by negative selection using MACS systems
(Miltenyi Biotec). CD4PD1CXCR5 cells were sorted by
FACS after staining with FITC-conjugated PD1, phycoerythrin-
conjugated CD4, and PerCP-conjugated CXCR5 antibodies.
Purified CD4 T cells were stimulated with plate-bound anti-
CD3 (clone 145-2C11, BD Biosciences) at 5 g/ml or at the
indicated concentrations and anti-CD28 (clone 37.51, BD Bio-
science) (2 g/ml) antibodies for the indicated times. B cells
were activated with soluble anti-F(ab)2 fragments of goat anti-
mouse IgM (anti-IgM F(ab)2, Jackson ImmunoResearch Labo-
ratories, Inc.) at 5 g/ml for the indicated times.
Microarray Analysis—Naive CD4 T cells were stimulated
with 5 g/ml anti-CD3 and 2 g/ml anti-CD28 for 16 h or left
unstimulated before extraction of total RNA. 250 ng of total
RNA was processed using the Ambion WT expression and
Affymetrix GeneChip WT terminal labeling kits according to
the manufacturers’ instructions. The labeled cDNA was then
hybridized toMouse Gene 1.0 ST arrays (Affymetrix) using the
GeneChip hybridization, wash, and stain kit (Affymetrix) and
scanned to generate .CEL files.
Array data were analyzed using R (20). Data were normalized
and summarized at the “core genes” level using the robust mul-
tiarray average method as implemented in the Bioconductor
oligo package (21). The data were filtered to remove transcripts
that had more than 50% of probe sets with a detection above
background p value greater than 0.05 and transcripts with
cross-hybridizing probe sets. Scatter plots were created using
the ggplot2 package (22).
For the clustered heat map, the data were filtered for tran-
scripts with expression values greater than 120 in any sample,
and probe sets associated with the same gene symbol were con-
solidated by selection of the probe set with the highest mean
expression. Data were “row-centered” by subtraction of the
mean expression level for each transcript, and transcripts anno-
tated with the GO term GO:0005125 (cytokine activity) were
selected. The final heat map was generated using a hierarchical
clustering algorithm, with relative expression levels repre-
sented by a relative color scale, using the gplots package (23).
Microarray data are available from the ArrayExpress database
under accession number E-MTAB-2432.
Quantitative Real-time PCR—Total RNA was extracted
from stimulated or unstimulated CD4 T cells or from
CD4PD1CXCR5 cells, using an RNeasy kit (Qiagen) or
TRIzol (Invitrogen) and reverse transcribed using oligo(dT)
primers (Amersham Biosciences). Quantitative real-time PCR
was performed on a Rotor-Gene system (Corbett Robotics)
using SYBR Green PCR master mix (Qiagen). Primers used in
PCR were as follows: IL21, 5-CTCAAGCCATCAAACCCTGG-3
(sense) and 5-CATACGAATCACAGGAAGGG-3 (antisense);
Bcl6, 5-CATGCAGGAAGTTCATCAAGG-3 (sense) and 5-
CTCAGTGGCATATTGTTCTCC-3 (antisense); Cxcr5, 5-TAT-
GGATGACCTGTACAAGGA-3 (sense) and 5-AGGATGTTTC-
CCATCATACCC-3 (antisense); Icos, 5-CAAGAAAGGAACCT-
TAGTGGA-3 (sense) and 5-CACTATTAGGGTCATGCACAC
-3 (antisense); Irf4, 5-CAGCTCATGTGGAACCTCTG-3 (sense)
and 5-TTGTTGTCTTCAAGTGGAAACCC-3 (antisense);
Prdm1, 5-AACCTGAAGGTCCACCTGAG-3 (sense) and
5-TGCTAAATCTCTTGTGGCAGAC-3 (antisense); Ascl2,
5-ACTGTCTAGAACTTTCCAACC-3 (sense)and5-AAACAT-
CAGCGTCAGTATAGG-3 (antisense);Egr2, 5-CTTCAGCCGA-
AGTGACCACC-3 (sense) and 5-GCTCTTCCGTTCCTTCT-
GCC-3 (antisense); Ifng, 5-CCATCAGCAACAACATAAGC-3
(sense) and 5-AGCTCATTGAATGCTTGGCG-3 (antisense);
Sh2d1a, 5-CCTGTAATAGCATCTCGCCTGAT-3 (sense) and
5-AGTTTTCCAATCCGCACTTTAAAG-3 (antisense).
The data were analyzed using the Rotor-Gene Software. All
samples were run in duplicate, and relative mRNA expression
levels were obtained by normalizing against the level of -actin
from the same sample under the same program using relative
expression 2ˆ(CT-actin-CT target) 10,000.
ChIP Assays—ChIP assays were performed according to the
protocol supplied with the kit (catalog no. 9003) from Cell Sig-
naling Technology. Briefly, 5  107 CD4 cells from wild type
mice were stimulated with anti-CD3 and anti-CD28 for 16 h.
The cells were then cross-linked with 1% formaldehyde for 10
min at room temperature. After quenching of formaldehyde
with 125mMglycine, chromatinwas sheared by sonication. The
fragmented chromatinwas around 300–1000 bp as analyzed on
agarose gels. After preclearing, chromatin (500 g) was sub-
jected to immunoprecipitation with specific anti-EGR2 anti-
body (eBioscience) or with anti-Ig as negative control at 4 °C
overnight. Immunocomplexes were recovered by incubation
with blocked protein G beads. DNA was purified according to
the kit and used as template for PCRwith specific primers: Bcl6
1 (intron1), 5-GAAGATGAACTGGATTCCTCCC-3 (sense) and
5-CCCTCAAAGCTCTTAACCGA-3 (antisense); Bcl6 2 (pro-
moter), 5- AAAGGTGAATACAGGGCAGAC-3 (sense) and 5-
GAAACAAGAGTCTCACTCATCC-3 (antisense); Bcl6 3 (down-
stream), 5-TGAATCACGGATGCATAAATGG-3 (sense) and5-
TGACCGACAGACATTCACAG-3 (antisense).
EMSA—The consensus probe for EGR2 (5-TGTAGGGGC-
GGGGGCGGGGTTA-3) was labeled with Cyanine5.5 (Sig-
ma-Aldrich) and used in binding reactions with nuclear
extracts from CD4 T cells stimulated with anti-CD3 and anti-
CD28 for 16 h and then restimulated for 30 min with phorbol
12-myristate 13-acetate and ionomycin (18, 19). For supershift
reactions, anti-EGR2 (eBioscience) was added after 10 min of
incubation. The samples were electrophoresed on 5% poly-
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acrylamide gels in 0.5 TBE. The gels were scanned using an
Odyssey Imager (LI-COR). For competition assays, oligonucle-
otides containing the three EGR2 binding sites from the Bcl6
locus, identified using Mulan (24) (Bcl6-1 (Chr16, 23983443–
23983464) 5-GGAGGGGGCGGGGGAGACAGCT-3; Bcl6-2
(Chr16,23990225–23990248)5-TTGCCCTCCTACTCATCCCT-
GGAT-3; and Bcl6-3 (Chr16, 23964461–23964482) 5-ACACAG-
GAGGAGGTGGCTGAGT-3) were added into the reaction mix-
tures prior to incubation.
Lentiviral Transduction—The lentiviral constructs for Egr2
or Bcl6 were constructed by PCR cloning. Egr2 was transferred
from an expression construct (18). Primers for Egr2 cloning
were 5-ACTCAGATCTCGAGGCCACCATGGACTACAAAG-
ACGATGACGACAAGACCGCCAAGGCCGTAGAC-3 (sense)
and 5-AGCTAGCTAGCGAGAATTCCTACAATTCCGG-3
(antisense), and those for Bcl6 were 5-AAGCTGGCTAGCG-
CCGCCATGGCCTCCCCGGCTGAC-3 (sense) and5-AGGGG-
CGGATCCTCAGCAGGCTTTGGGGAGC-3 (antisense). The
constructs were confirmed by sequencing. In addition to Egr2
or Bcl6, the constructs carry an internal ribosome entry site-
driven GFP, which allows us to isolate transduced cells by fluo-
rescence-activated cell sorting. Naive CD4 cells from CD2-
Egr2/Egr3/ mice at 1  106 cells/well in a 24-well plate
coated with anti-CD3 and anti-CD28 were infected with con-
centrated lentivirus at a multiplicity of infection of 50–100
(105 to 106 transducing units/ng of p24) as described previ-
ously (19). The infected cells were incubated at 37 °C for 7 h
with gentle shaking before the addition of 1 ml of medium. The
cells were harvested after 24 h, and the GFP-positive cells were
isolated by cell sorting.
Viruses—VVWR stocks were grown using TK143 cells in
T175 flasks, infected at a multiplicity of infection of 0.5. Cells
were harvested at 72 h, and virus was isolated by rapidly freeze-
thawing the cell pellet three times in 5ml of DMEM containing
10% fetal calf serum (FCS) as described previously (25). Cell
debris was removed by centrifugation. Clarified supernatant
was frozen at80 °C as virus stock. VVWR stocks were titrated
using TK143 cells.
Viral Infection—Micewere infected intranasally with 2 105
pfu of vaccinia virus in 10 l of physiological saline. The mice
were weighed and observed for illness daily, as described previ-
ously (25). In vivo replication of vaccinia virus was examined by
plaque assay on lung tissue samples, which were removed,
weighed, and ground with a mortar and pestle. Serial 10-fold
dilutions of clarified supernatants were used to infect subcon-
fluent monolayers of TK143 cells in triplicate in 24-well plates.
The cells were fixed with formalin 2 days after infection and
stained with 2% crystal violet in 40% methanol, and plaques
were counted under a dissecting microscope.
Plaque Reduction Neutralization Tests—TK143 cells were
seeded into 24-well Costar plates (Corning Inc.) and used
within 2 days of reaching confluence. Sera were diluted in
DMEM. The serially diluted sera were then incubated with an
equal volume of VVWR (2 104 pfu/ml) overnight at 37 °C. The
cells were rinsed in serum-free medium, the medium was aspi-
rated, and 100l of virus/serummixturewas added to eachwell
in duplicate and left to adsorb for 60 min at 37 °C with periodic
swirling. Thewells were thenwashedwith serum-freemedium,
and normal growth medium was added. After allowing 2 days
for the plaques to develop, the cells were fixed and stained in
one stepwith 0.1% crystal violet in 20% ethanol, and the plaques
were quantified over white light transillumination.
Adoptive Transfer—2 106 naive CD4 T or resting B cells
from 4-week-old wild type mice were suspended in 100 l of
physiological saline and injected intravenously into the dorsal
tail vein of 6-week-old CD2-Egr2/Egr3/ mice. 24 h after
transfer, the recipient mice were infected intranasally with 2
105 pfu of vaccinia virus. 14 days after infection, Tfh and GC B
cells and GC formation were analyzed. For Rag2/ experi-
ments, either (a) 2.5  106 naive wild type CD4 T and 2.5 
106 resting wild type B cells or (b) 2.5  106 naive wild type
CD4 T and 2.5  106 resting B cells from CD2-Egr2/
Egr3/ mice or (c) 2.5  106 resting wild type B cells and
2.5  106 naive CD4 cells from CD2-Egr2/Egr3/ mice
were suspended in 100 l of physiological saline and injected
intravenously into the dorsal tail vein of Rag2/ mice. Forty
days after transfer, recipient mice were infected intranasally
with 2  105 pfu of vaccinia virus. For adoptive transfer of
transduced cells, 1 106 EGR2- or BCL6-transduced EGR2/3-
deficient CD4 cells were suspended in 100 l of physiological
saline and injected intravenously into the dorsal tail vein of
CD2-Egr2/Egr3/mice. Tfh andGCB cells andGC forma-
tion were analyzed 14 days after infection.
Generation of Bone Marrow Chimeras—Bone marrow was
collected from CD2-Egr2/Egr3/ (CD45.2) and wild type
C57BL/6 (CD45.1) mice. For each chimera, 20 106 cells of a
1:1 mixture of CD2-Egr2/Egr3/ and C57BL/6 bone mar-
row cells were transferred intravenously into lethally irradiated
(two doses of 550 rads) wild type C57BL/6 (CD45.1) recipi-
ents. Recipient mice were allowed 8 weeks to recover following
reconstitution before intranasal infection with 2  105 pfu of
vaccinia virus. 14 days after infection, Tfh andGCBcells among
gated CD45.1 and CD45.2 cells were analyzed.
Immunohistochemistry Analysis—Spleen tissue sections were
fixed with 4% paraformaldehyde in PBS and embedded in par-
affin or by 1:1 acetone/methanol fixation for frozen sections.
Paraffin sections were stainedwith hematoxylin and eosin. His-
tological examination of tissue sections was done in a blind
manner. Frozen sections were stained with TRITC-conjugated
peanut agglutinin (PNA; Sigma), Alexa Fluor 647-labeled anti-
IgD (Biolegend), and FITC-labeled anti-CD4 mAb (BD Biosci-
ences). Paraffin sections were stained using rat anti-mouse
B220 (BD Biosciences), which was detected using anti-rat
FITC-labeled IgG (Sigma), and rabbit anti-CD3 (DAKO),
which was detected using anti-rabbit Alexa Fluor 647-labeled
IgG (Invitrogen), together with TRITC-conjugated PNA
(Sigma). Stained sections were washed in phosphate-buffered
saline (PBS) andmounted using Vectashield (Vector Laborato-
ries, Burlingame, CA).
Statistics—Graphs were generated using the using the R
package ggplot2 (22). A two-tailed non-parametric Mann-
Whitney test was used to analyze the statistical significance of
differences between groups using the R package coin (26). Dif-
ferences with a p value of0.05 were considered significant.
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Results
Altered Expression of BCL6 and BLIMP1 in EGR2/3-deficient
CD4 TCells—EGR2 and -3 have overlapping functions in T cell
receptor-mediated responses (19). To assess the mechanisms,
we analyzed the global gene expression patterns of EGR2- and
EGR3-deficient CD4 T cells. CD4 T cells were isolated from
wild type and CD2-Egr2/Egr3/ mice at 2 months of age
and stimulated with anti-CD3 and anti-CD28 for 16 h, and the
global gene expression patterns of these cells were analyzed. A
total of 482 genes were found to be differentially expressed,
using a threshold of 3-fold, in EGR2- and EGR3-deficient CD4
T cells compared with wild type counterparts (ArrayExpress
accession number E-MTAB-2432). Among the genes that were
increased in EGR2- and EGR3-deficient T cells, there was a
large number of inflammatory cytokines and chemokines (Fig.
1A), consistent with our previous findings of increased inflam-
matory responses of EGR2- and EGR3-deficient T cells (19).
Interestingly, amongthegenes thatweredifferentiallyexpressed in
EGR2- and EGR3-deficient CD4 cells were some of the key
regulators of Tfh cells (Fig. 1B). The expression of Bcl6 was
reduced, whereas, in contrast, BLIMP1 (encoded by Prdm1), a
repressor of Bcl6, was increased in EGR2/3-deficient CD4 T
cells (Fig. 1B). The altered expression of Bcl6 and BLIMP1 was
confirmed by real-time PCR (Fig. 1C). Notably, despite the
defects in Bcl6 expression in EGR2- and EGR3-deficient CD4T
cells, a low level of Bcl6 could still be induced in response to T
cell receptor stimulation (Fig. 1C), indicating that EGR2 and -3
are not the only transcription factors that regulate Bcl6 expres-
sion. To analyze the expression of these genes in Tfh cells,
CD4CXCR5PD1 cells (Fig. 1D) were isolated from CD2-
Egr2/Egr3/ and wild type mice and analyzed for expres-
sion of Bcl6 and BLIMP1 by real-time PCR. Notably,
CD4CXCR5PD1 cells were significantly reduced in CD2-
Egr2/Egr3/ mice (Fig. 1D). The expression of Bcl6 was
severely defective in EGR2- and EGR3-deficient Tfh cells,
whereas BLIMP1 expression was increased (Fig. 1E).
To assess the consequences of defective Bcl6 expression in
Tfh cells in CD2-Egr2/Egr3/ mice, we analyzed Tfh cells
after vaccinia virus infection. We discovered that the differen-
tiation ofTfh cells in response to virus infectionwas defective in
CD2-Egr2/Egr3/mice compared with wild type counter-
parts (Fig. 2, A and C). Consistently, the expression of BCL6 in
CD4CXCR5PD1 cells from CD2-Egr2/Egr3/ mice
was reduced (Fig. 2B). Thus, EGR2/3 are important for the
expression of BCL6 in Tfh cells and the development of Tfh
cells. The lack of Tfh cells was not due to a failure to activate
EGR2/3-deficient CD4 T cells because EGR2/3-deficient
CD4 T cells did not have defects in activation marker expres-
sion, as indicated by CD44high cell frequency (Fig. 2D), or
effector cytokine expression (Fig. 2E) in response to viral
infection. We did not detect similar defects in Tfh cells in
CD2-Egr2/ or Egr3/ mice (data not shown), suggesting
FIGURE1.AlteredexpressionofTfhcell genes inEGR2/3-deficientCD4Tcells.A, heatmappresentationofdifferentially expressedcytokinegenes (GOterm
GO:0005125) from unstimulated () and anti-CD3- and anti-CD28-stimulated () CD4 T cells fromWT and CD2-Egr2/Egr3/ (K2-3) mice. B, scatter plot of
gene expression levels for anti-CD3- and anti-CD28-stimulated CD4 T cells fromWT and K2-3 mice. Dotted blue line, equivalent expression between samples;
dashed brown lines, 3-fold differential expression between WT and K2-3. Bcl6, Egr2, and Prdm1 (BLIMP1) are highlighted. C, differential expression of Bcl6 and
BLIMP1was confirmed by RT-PCR using unstimulated and anti-CD3- and anti-CD28-stimulated CD4 T cells fromWT and K2-3mice.D, CXCR5PD1 cells from
WT and K2-3 mice were analyzed after gating on the CD4 population. E, relative expression of the indicated genes in CD4CXCR5PD1 and
CD4CXCR5PD1 cells. RT-PCR results in C and E are presented relative to the expression of -actin mRNA. Data in C and E represent three independent
experiments.
EGR2 and -3 Regulate Tfh Differentiation
20458 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 290•NUMBER 33•AUGUST 14, 2015
 at B
RU
N
EL U
N
IV
 on July 19, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
an overlapping function of EGR2 and -3 in regulation of Tfh
development.
EGR2- and EGR3-mediated Tfh Differentiation Is Important
for GC Formation—Tfh cells are essential for the development
of GCs in response to virus infections (1, 2). In response to
vaccinia virus infection, GCs were rapidly generated in spleens
of wild type mice together with high levels of GL7-positive GC
B cells (Fig. 3, A–C). However, virus infection did not induce
GC formation in CD2-Egr2/Egr3/mice, and the develop-
ment of GC B cells was severely impaired (Fig. 3, A–C). Inter-
estingly, BCL6 expression in GL7-positive B cells from CD2-
Egr2/Egr3/ mice was largely normal compared with wild
typeGCB cells (Fig. 3B). Furthermore, we found that EGR2was
not expressed in GL7-positive B cells from virus-infected wild
type mice (Fig. 3D), whereas Egr3 expression was also not
detected in these cells by RT-PCR (data not shown). These results
suggest that defective GC formation in CD2-Egr2/Egr3/
mice results fromimpaired functionofEGR2-andEGR3-deficient
Tfh cells.
Following viral infection, CD2-Egr2/Egr3/ mice dis-
played more severe clinical signs than wild type counterparts
(Fig. 3E), and viral load in the lungs of CD2-Egr2/Egr3/
mice was much higher than that in wild type counterparts (Fig.
3F). Consistent with the clinical pathology, the titer of neutral-
izing antibody was much lower in CD2-Egr2/Egr3/ mice
than wild type counterparts (Fig. 3G), demonstrating that the
generation of virus-specific antibodies was impaired in CD2-
Egr2/Egr3/mice. Thus, EGR2/3 are important for BCL6-
mediated Tfh differentiation, Tfh cell-mediated GC reactions
in anti-viral immune responses, and production of virus-spe-
cific antibodies that are required for effective viral clearance.
EGR2/3 Regulate Tfh Differentiation but Not GC B Cell
Development—EGR2 and -3 can be induced in both B and T
cells by antigen receptor stimulation and function in the main-
tenance of B and T cell homeostasis (19). To investigate the
possibility that defects in the GC reaction result from the defi-
ciency of EGR2/3 in B cells, CD4 or B cells from wild type mice
were adoptively transferred to congenic CD2-Egr2/Egr3/
mice. The recipientmicewere then infectedwith vaccinia virus.
Transfer ofwild typeCD4Tcells toCD2-Egr2/Egr3/mice
increased the numbers of Tfh and GC B cells and effectively
restoredGC formation (Fig. 4,A–C). In contrast, GC formation
was not detected in CD2-Egr2/Egr3/ mice that received
wild type B cells (Fig. 4, A–C). To exclude environmental dif-
ferences betweenwild type andCD2-Egr2/Egr3/mice, we
analyzed Tfh development in mixed chimeras reconstituted
with bone marrow from wild type and CD2-Egr2/Egr3/
mice. Eight weeks after bonemarrow reconstitution, we did not
observe enlarged peripheral lymphoid organs or overt autoim-
mune disease in chimericmice. Chimericmice had similar anti-
viral responses to wild typemice after virus infection. However,
development of Tfh cells from EGR2- and EGR3-deficient, but
not wild type, CD4 T cells was impaired (Fig. 4, D and E). In
contrast, there were no differences in the development of GC B
cells from wild type and EGR2/3-deficient B cells (Fig. 4D).
FIGURE 2. Impaired Tfh differentiation in CD2-Egr2/Egr3/mice.WT and CD2-Egr2/Egr3/ (K2-3) mice were infected intranasally with 2 105 pfu
of vaccinia virus. A and C, Tfh cells inWT and K2-3mice 14 days postinfectionwere analyzed by flow cytometry using the indicatedmarkers after gating on the
CD4 population (A), and CXCR5PD1 cells were quantified as a percentage of total CD4 cells (C). B, BCL6 expression by CD4CXCR5PD1 and
CD4CXCR5PD1 cells in WT and K2-3 mice 14 days postinfection was analyzed by flow cytometry. D and E, CD4 T cells from WT and K2-3 mice 7 days
postinfection were analyzed for expression of CD44 by flow cytometry (D) and production of effector cytokines by RT-PCR (E). In C, each symbol represents an
individual mouse from three independent experiments (indicated by different colored symbols); error bars, S.E. on either side of the mean. *, p  0.0005
(Mann-Whitney two-tailed test). E, mRNA samples were pooled from four mice, and RT-PCR results are presented relative to the expression of -actin mRNA.
Data are representative of at least two independent experiments.
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These results indicate that EGR2- and EGR3-deficient T cells
have an intrinsic defect in Tfh development.
To further test whether the defective GC reaction in CD2-
Egr2/Egr3/mice is due to the function of EGR2 and -3 in
B cells, we reconstituted B andT cells inRag2/mice by adop-
tive transfer of either wild type naive CD4 T cells in combina-
tion with EGR2/3-deficient B cells or EGR2/3-deficient naive
CD4 T cells together with wild type B cells. Rag2/mice that
receivedwild type naiveCD4T cells andwild type B cells served
as a control. Despite transfer of the same number of cells, the
total number of B cells detected in Rag2/ recipient mice was
only one-fifth of the number of CD4 T cells (data not shown),
which is consistent with a previous report (27). However, even
with few B cells, Tfh cells, GC B cells, and GC formation were
detected in mice that received wild type CD4 and EGR2/3-de-
ficient B cells (Fig. 5, A–C), with levels similar to those seen in
mice that received wild type CD4 and wild type B cells (Fig. 5,
A–C). In contrast, significantly fewer Tfh cells and GC B cells
were observed inmice that received EGR2/3-deficient CD4 and
wild type B cells (Fig. 5, A and B). Moreover, GCs were not
detected in spleens from these mice (Fig. 5C). These results
indicate that EGR2/3-deficient B cells respond normally to wild
type Tfh cells for GC development. Thus, defective Tfh differ-
entiation, but not B cell function, inCD2-Egr2/Egr3/mice
leads to the deficiency in GC formation.
EGR2 Directly Regulates Bcl6 Expression—The defective
expression of BCL6 in EGR2/3-deficient Tfh cells suggests that
EGR2/3may regulate the expression ofBcl6 in T cells. To inves-
tigate this possibility, we analyzed conserved regulatory regions
of the Bcl6 locus and found three potential binding sites for
EGR2: one in the first intron (site 1), one in the promoter region
(site 2), and one downstreamof the gene (site 3) (Fig. 6A). Chro-
matin immunoprecipitation (ChIP) analysis demonstrated that
EGR2 in CD4 T cells bound to two of these three sites (sites 2
and 3) (Fig. 6B). To further confirm the interaction of EGR2
with these sites in the Bcl6 locus, we assessed the ability of
oligonucleotides derived from these binding sites to compete
with a probe containing the consensus EGR2 binding sequence
for EGR2 interaction. Indeed, these oligonucleotides efficiently
competed for EGR2 binding with the sequence from the pro-
moter of Bcl6 as the most effective competitor (Fig. 6C). Thus,
EGR2 can directly interact with conserved elements of the Bcl6
locus, indicating that EGR2 regulates the expression of Bcl6 in
T cells. To confirm the role of EGR2 in the expression of Bcl6,
EGR2/3-deficient CD4 T cells were transduced with lentivirus
encoding EGR2 or BCL6. Restoration of EGR2 expression
effectively induced Bcl6 expression in EGR2/3-deficient CD4 T
cells (Fig. 6D). Interestingly, expression of BLIMP1was reduced
in EGR2/3-deficient CD4 T cells by transduction of either
EGR2 or BCL6 (Fig. 6D), indicating that BCL6 expression is
important to suppress BLIMP1 expression as described previ-
ously (28).
Following virus infection, most of the Tfh cells in wild type
mice expressed BCL6, whereas BCL6 expression was defective
in the few remaining Tfh cells in CD2-Egr2/Egr3/ mice
(Fig. 6E). Moreover, the EGR2-positive Tfh cells expressed
higher levels of BCL6 than did EGR2-negative cells in wild type
mice (Fig. 6E). In contrast to BCL6, the expression levels of
other genes involved in Tfh differentiation, such as Irf4, c-Maf,
Ascl2, and Sh2d1a (3, 12–14, 17), were similar in wild type and
EGR2/3-deficient Tfh cells (data not shown). Thus, EGR2/3
FIGURE 3. Impaired anti-viral B cell responses and increased clinical signs in CD2-Egr2/Egr3/mice.WT and CD2-Egr2/Egr3/ (K2-3) mice were
infected intranasally with 2  105 pfu of vaccinia virus. A, splenic sections from WT and K2-3 mice 14 days postinfection were stained with PNA (red) and
antibodies against CD4 (green) and IgD (blue). B, GC B cells (B220GL7) were analyzed inWT and K2-3mice by flow cytometry 14 days postinfection, and the
expression of BCL6 (bottom) was analyzed. C, GC B cells in thesemicewere quantified as a percentage of total B220 cells (gating as in B).D, EGR2 expression by
B220GL7 cells inWT andK2-3mice 14 days postinfectionwas analyzed. E, percentageweight loss of infectedWT andK2-3mice at the indicated timepoints.
F, viral titer in lung tissue specimens from WT and K2-3 mice 8 days after infection. G, serum was collected from infected WT and K2-3 mice 3 weeks after
infection, and the presence of antiviral antibody was assessed using a neutralization assay. The number of viral plaques in the presence of serum at the
indicated dilutions is shown. Results are presented as mean 	 S.E. (error bars) from groups of five mice of each genotype. C, each symbol represents an
individual mouse from three independent experiments (indicated by different colored symbols); error bars, S.E. on either side of the mean. *, p  0.0005
(Mann-Whitney two-tailed test). Data are representative of at least two independent experiments.
EGR2 and -3 Regulate Tfh Differentiation
20460 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 290•NUMBER 33•AUGUST 14, 2015
 at B
RU
N
EL U
N
IV
 on July 19, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
regulate Tfh differentiation by controlling Bcl6 expression in
Tfh cells.
Restoration of TfhDifferentiation andGCFormation in CD2-
Egr2/Egr3/ Mice by EGR2 or BCL6 Transduction into
EGR2/3-deficient CD4TCells—To examinewhether reinstated
EGR2 expression or forced expression of BCL6 can restore Tfh
cell function in vivo, EGR2/3-deficient CD4 T cells transduced
with EGR2 or BCL6 were adoptively transferred into CD2-
Egr2/Egr3/ mice. The recipient mice were then infected
with vaccinia virus. Two weeks after infection, Tfh cells, GC B
cells, and GC formation were analyzed. CD4CXCR5PD1
cells were significantly increased in mice that received
EGR2-transduced EGR2/3-deficient CD4 T cells (Fig. 7A).
Consistent with this, transfer of EGR2-transduced EGR2/3-
deficient CD4 T cells increased the percentage of GC B cells
(Fig. 7A) and restored GC formation (Fig. 7B). Similarly,
transfer of BCL6-transduced EGR2/3-deficient CD4 T cells
increased the Tfh cell population in CD2-Egr2/Egr3/
mice and the percentage of GC B cells (Fig. 7C). In addition,
a significant level of GCs was detected in mice that received
BCL6-transduced EGR2/3-deficient CD4 T cells (Fig. 7D).
These results demonstrate that EGR2-mediated Bcl6 expres-
sion in Tfh cells is one of the mechanisms for Tfh cell devel-
opment and function.
Discussion
EGR2/3 have multiple functions in T cells and are essential
for the control of lymphocyte homeostasis and antigen recep-
tor-mediated proliferation (18, 19, 29, 30). However, their roles
in effector T cell function are not clear. Here we have discov-
ered a novel function of EGR2/3 in regulation of Bcl6 expres-
sion in Tfh cells and Tfh differentiation. We found defective
expression of BCL6 in EGR2/3-deficient CD4 T cells, whereas
the expression of BLIMP1, a repressor of Bcl6 (4, 28), was
increased, which led to impaired Tfh differentiation and GC
reactions in CD2-Egr2/Egr3/mice. The reduced produc-
tion of neutralizing antibodies andmore severe clinical signs in
virus-infectedCD2-Egr2/Egr3/mice, comparedwithwild
type counterparts, demonstrated an important function of
EGR2/3 in the regulation of Tfh cell-mediated B cell responses.
BLIMP1 expression in EGR2/3-deficient CD4 T cells was
reduced after forced expression of BCL6, suggesting that
altered expression of BLIMP1 is largely due to the impaired
expression of BCL6 in EGR2/3-deficient Tfh cells. Interest-
ingly, although EGR2/3 can be induced in B cells by antigen
stimulation in vitro (19), GC B cells did not express EGR2, and
the levels of BCL6 expression in EGR2/3-deficient GC B cells
were normal, suggesting that EGR2/3 are not intrinsically
involved in the development of GC B cells. Our findings dem-
FIGURE 4. ImpairedGC formation in CD2-Egr2/Egr3/mice results fromdefective Tfh cells, not GCB cell defects. A–C, wild type CD4 or B220 cells
were adoptively transferred into congenicCD2-Egr2/Egr3/ (K2-3)mice at 2 106 cells/mouse. 24 h after transfer,micewere infected intranasallywith 2
105 pfu of vaccinia virus and analyzed 14 days postinfection. A, GC B cells were analyzed by flow cytometry. B, GC B cells in K2-3 mice () and K2-3 mice that
received WT CD4 (CD4) or WT B220 (B220) cells were quantified as a percentage of total B220 cells. C, splenic sections were stained with PNA (red) and
antibodies against CD4 (green) and IgD (blue).D and E, chimeric mice were generated by reconstitution with an equal number of bonemarrow cells fromwild
type (CD45.1) andK2-3mice (CD45.2). 8weeks after reconstitution, chimericmicewere infected intranasallywith2105pfuof vaccinia virus andanalyzed14d
after infection. D, Tfh and GC B cells were analyzed by flow cytometry after gating on CD45.1 or CD45.2 populations; Tfh cells were also gated on CD4 cells. E,
CXCR5PD1 cells were quantified as a percentage of total CD45.1CD4 or CD45.2CD4 cells. In B and E, each symbol represents an individual mouse, and the data
represent three independent experiments with similar results; error bars, S.E. on either side of the mean. *, p  0.01; N.S., not significant (Mann-Whitney
two-tailed test). Data are representative of three independent experiments with three or four mice in each group.
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onstrate a novel function of EGR2/3 in regulation of Bcl6
expression and Tfh differentiation.
Recent studies have demonstrated that the development of
Tfh cells involves at least two stages: an initial prefollicular stage
and final maturation in the follicular regions (3). This paradigm
is based on the findings from studies of key molecules involved
in the regulation of Tfh cell chemotaxis, such as CXCR5, ICOS,
and SH2D1A, and differentiation and survival, such as BCL6 (1,
3, 12, 17). CXCR5, ICOS, and SH2D1A are essential for Tfh cell
migration to follicles and the initiation of Tfh differentiation (1,
3, 12, 17). CXCR5 is expressed in interfollicular Tfh cell precur-
sors and is essential for the development of Tfh cells (3). Ascl2,
a Tfh cell-specific transcription factor, has been found to
induce CXCR5 expression on Tfh cell precursors, leading to
migration to the follicles, where they acquire high levels of
BCL6 (3). Despite the severe reduction of CXCR5PD1 CD4
T cell numbers in CD2-Egr2/Egr3/ mice, the expression
levels of Cxcr5, Icos, and Sh2d1a in EGR2/3-deficient Tfh cells
were normal, suggesting that EGR2/3 may not be involved in
the early stage of Tfh differentiation.
BCL6 is not involved in the early stage of Tfh development,
but it is the key transcription factor for both Tfh differentiation
and GC B cell maturation (2, 4–6). However, the function of
BCL6 in the regulation of GCB cell reactions in B cells is largely
distinct from its function in Tfh cells (31). Although we do not
knowwhether EGR2 and -3 can regulateBcl6 in B cells, the lack
of EGR2 expression in GC B cells from wild type mice and
normal levels of BCL6 in GC B cells in CD2-Egr2/Egr3/
mice indicate differences in the regulation of Bcl6 expression in
GC B and Tfh cells. BATF is one of the regulators of Bcl6
expression in T cells and is important for Tfh differentiation by
regulation of Bcl6 and c-Maf expression (13). EGR2 interacts
with BATF and blocks its function in suppression of AP1 activ-
ity in activated T cells (19). The enhanced BATF activity and
impaired Tfh differentiation in EGR2/3-deficient CD4 T cells
suggest that interaction with EGR2 does not prevent the tran-
scriptional activity of BATF in Bcl6 expression.
In addition to Tfh function, BCL6 controls immune homeo-
stasis, with Bcl6/ mice displaying systemic inflammation
associated with overproduction of Th2 cytokines (8, 32). CD2-
Egr2/Egr3/mice also develop systemic inflammationwith
the development of self-reactive antibodies and lupus-like dis-
ease, which partly resembles BCL6-deficient mice (8, 19, 32).
Although we cannot exclude the effects of the inflammatory
phenotype of EGR2- and EGR3-deficient T cells completely,
the effective Tfh differentiation of wild type, but not EGR2- and
FIGURE 5. EGR2/3-deficient CD4 T cells failed to induce GC formation in Rag2/ mice. Naive CD4 and B cells were isolated from wild type and CD2-
Egr2/Egr3/ mice. Wild type CD4 cells were mixed with EGR2/3-deficient B cells (WT-CD4/K2-3-B220), and wild type B cells were combined with
EGR2/3-deficient CD4 cells (K2-3-CD4/WT-B220) at equal cell numbers of B and CD4 cells. Wild type CD4 cells together with wild type B cells (WT-CD4/
WT-B220) served as a control. These mixtures of cells were then adoptively transferred into Rag2/ mice. 40 days after transfer, recipient mice were
infected intranasally with 2 105 pfu of vaccinia virus and analyzed 14 days after infection. A, CD4 and B220 cells from spleen and lymph nodes were
gated for analysis of CD4CXCR5PD1 Tfh cells (left) and B220GL7 GC B cells (right). B, CXCR5PD1 and B220GL7 populations were quantified
as a percentage of total CD4 or B220 cells. C, splenic tissue sections were stained with anti-B220 (blue), PNA (red), and anti-CD3 (green). In B, each
symbol represents an individual mouse from two independent experiments (indicated by different colored symbols); error bars, S.E. on either side of the
mean. *, p 0.01; N.S., not significant (Mann-Whitney two-tailed test). Data are representative of two independent experiments with three mice in each
group.
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EGR3-deficient, CD4 T cells in chimeric mice suggests that
EGR2 and -3 have an intrinsic function in Tfh development.
Furthermore, in addition to defective Tfh differentiation, the
impaired expression of BCL6 in T cells may also contrib-
ute to the development of inflammatory disorders in CD2-
Egr2/Egr3/ mice. Thus, similar to BCL6, EGR2 and -3
have dual function in the control of inflammation and regula-
tion of Tfh development.
Recently, it has been found that IL-6-mediated STAT1 acti-
vation is important for Bcl6 induction and early Tfh differenti-
ation in vivo (33, 34). In addition to STAT1, STAT3 has also
been found to enhance Tfh differentiation (35). However,
STAT3 function in enhancing Tfh differentiation is indepen-
dent of BCL6; instead, STAT3 limits Th1 differentiation
through down-regulation of IL-2Ra (33). In contrast to STAT1
and STAT3, STAT5 activation induced by IL-2R signaling neg-
atively regulates Tfh differentiation (36). However, because
STAT1 and STAT3 also function in Th1 and Th17 differentia-
tion, their roles in Tfh differentiationmay depend upon factors
such as when and where the stimulating cytokines are pro-
duced, whether their receptors are expressed, and also the
interplay between these and other signaling pathways, includ-
ing other STATS. We found that EGR2/3 indirectly control
STAT1 and STAT3 activation in activated T cells by regulating
SOCS1 and SOCS3 expression to prevent excessive production
of Th1 and Th17 cytokines (19), suggesting that STAT1 and
STAT3 have different functions in the initial activation of anti-
gen-stimulated T cells and Tfh differentiation.
In summary, we have discovered a novel function of EGR2/3
in regulation of Tfh differentiation by controlling the expres-
sion of Bcl6. This EGR2/3-mediated Tfh differentiation is
important for GC reactions and production of antiviral anti-
bodies. Thus, in addition to promoting antigen receptor-in-
duced proliferation and inhibiting the inflammatory responses
FIGURE 6. EGR2 directly regulates Bcl6 expression in CD4 T cells. A, identification of three potential binding sites for EGR2 in conserved regions of the Bcl6
locus usingMulan andmultiTF (24). B, to determinewhether EGR2 interactswith these sites, CD4 T cells fromwild typemicewere stimulatedwith anti-CD3 and
anti-CD28 for 16 h and used in a ChIP assay with primers flanking two of the potential EGR binding sites (sites 2 and 3) in the Bcl6 locus. Total input DNA and
anti-Ig precipitates served as positive and negative controls, respectively. C, interaction of EGR2 with probes derived from the potential binding sites (sites 1,
2, and 3) in the Bcl6 locus by EMSA. The EGR2 consensus binding sequence probe interactedwith EGR2 fromnuclear extracts of wild type CD4 T cells that were
stimulated by anti-CD3 and anti-CD28 antibodies for 16 h (lane 1). The EGR2 probe band can be supershifted by the addition of anti-EGR2 antibody (lane 3) but
not control IgG (lane 2). Probes derived from the potential EGR2 binding sites in the Bcl6 locus (sites 1, 2, and 3) (lanes 6–8), but not an AP-1 probe (lane 5),
competed for EGR2binding. Nuclear extract fromEGR2/3-deficient CD4 T cells stimulatedby anti-CD3 and anti-CD28 for 16 h served as a negative control (lane
4). D, RT-PCR analysis of Bcl6, BLIMP1, and Egr2 in EGR2/3-deficient CD4 T cells 24 h after transduction with control lentivirus or lentivirus encoding EGR2 (left)
or BCL6 (right). Error bars, SD. E, BCL6 and EGR2 expression in Tfh cells inWT andCD2-Egr2/Egr3/ (K2-3)mice 14 days after vaccinia virus infection. Data are
representative of three (B, C, and E) or two (D) independent experiments. The RT-PCR expression results are presented relative to the expression of -actin
mRNA.
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of T cells, EGR2/3 are crucial for generation of high affinity
antibody responses.
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